Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run) (MMS-R-ep)

March 11, 2026 updated by: Centre Hospitalier Universitaire de la Réunion

Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run) : Preliminary Study

Illeteracy concerns more than 38% of Réunion Island's people older than 65 years old, which makes it an important risk factor for dementia and a limit to neurocognitive test's administration.

The MMSRun is a Mini Mental State Examination's version adapted to illeteracy and Réunionese culture, inspired by Hindi Mental State Examination's work. It allows a way better participation during neurocognitive evaluation, but it has never been validated.

This study is a peliminary study to a validation, where the concordance between scores obtained from MMSRun and from the consensual version of Mini Mental State Examination proposed by GRECO (Groupe de Réflexion sur les Evaluations Cognitives) - the only french version validated - on a hospitalized and eldery population will be analyzed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

61

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Reunion
      • Saint-Denis, Reunion, 97400
        • CHU de La Réunion

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients will be selected in geriatric and physical medicine and rehabilitation departments at CHU de La Réunion.

Description

Inclusion Criteria:

  • Patient who needs a cognitive evaluation by MMSe/MMS-RUN during usual medical care
  • Patient born and living in Réunion Island
  • Patient hospitalized in geriatrics department or in the departement of physical medecine and rehabilitation
  • Patient who agrees to participate in the study and who does not oppose to the use of his data

Exclusion Criteria:

  • Patient with hearing and visual disorder that can interfere in cognitive test administration
  • Patient with altered state of consciousness (Glasgow score different of 15)
  • Patient diagnosed or having symtoms compatible with a psychiatric pathology with psychosis (altered perception of reality)
  • Patient with a current and severe addiction to Alcohol or any other drug (smoking excluded)
  • Patient deprived of liberty by judicial or administrative decision and patient under curatorship or guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total scoring of MMSE
Time Frame: Day 0

30 questions, good response to a question = 1, bad response to a question = 0, global scoring between 0 and 30,

Pathological threshold according to the socio-cultural level :

  • without diploma : total score <22
  • secondary education without the 3rd class : total score <23
  • secondary education from 3rd class to the senior year class (without bachelor degree)
  • higher education : total score <26
Day 0
Total scoring of MMS-RUN
Time Frame: Day 1

30 questions, good response to a question = 1, bad response to a question = 0, total score between 0 and 30,

Pathological threshold according to the socio-cultural level :

  • without diploma : total score <22
  • secondary education without the 3rd class : total score <23
  • secondary education from 3rd class to the senior year class (without bachelor degree)
  • higher education : total score <26
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de la Réunion

Investigators

  • Principal Investigator: Bénédicte CASALONGA, MD, CHU de La Réunion

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2023

Primary Completion (Actual)

April 12, 2024

Study Completion (Actual)

April 12, 2024

Study Registration Dates

First Submitted

April 25, 2023

First Submitted That Met QC Criteria

May 4, 2023

First Posted (Actual)

May 15, 2023

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 11, 2026

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022/CHU/30

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe